- Report
- March 2026
- 295 Pages
Global
From €5261EUR$5,850USD£4,537GBP
- Report
- February 2026
- 250 Pages
Global
From €4038EUR$4,490USD£3,482GBP
- Report
- June 2025
- 138 Pages
Global
From €3596EUR$3,999USD£3,102GBP
- Report
- August 2025
- 122 Pages
North America
From €3596EUR$3,999USD£3,102GBP
- Report
- January 2026
- 192 Pages
Global
From €3188EUR$3,545USD£2,749GBP
€3542EUR$3,939USD£3,055GBP
- Drug Pipelines
- April 2025
- 60 Pages
Global
From €1799EUR$2,000USD£1,551GBP
- Report
- July 2025
- 350 Pages
Global
From €4450EUR$4,949USD£3,838GBP
- Report
- August 2025
- 150 Pages
Global
From €3552EUR$3,950USD£3,064GBP
- Report
- January 2026
- 199 Pages
Global
From €3188EUR$3,545USD£2,749GBP
€3542EUR$3,939USD£3,055GBP
- Report
- January 2026
- 190 Pages
Global
From €3188EUR$3,545USD£2,749GBP
€3542EUR$3,939USD£3,055GBP
- Report
- January 2026
- 187 Pages
Global
From €3188EUR$3,545USD£2,749GBP
€3542EUR$3,939USD£3,055GBP
- Report
- January 2026
- 182 Pages
Global
From €3188EUR$3,545USD£2,749GBP
€3542EUR$3,939USD£3,055GBP
- Report
- January 2026
- 191 Pages
Global
From €3188EUR$3,545USD£2,749GBP
€3542EUR$3,939USD£3,055GBP
- Report
- January 2026
- 196 Pages
Global
From €3188EUR$3,545USD£2,749GBP
€3542EUR$3,939USD£3,055GBP
- Report
- August 2025
- 192 Pages
Global
From €3188EUR$3,545USD£2,749GBP
€3542EUR$3,939USD£3,055GBP
- Report
- August 2025
- 189 Pages
Global
From €3188EUR$3,545USD£2,749GBP
€3542EUR$3,939USD£3,055GBP
- Report
- August 2025
- 184 Pages
Global
From €3188EUR$3,545USD£2,749GBP
€3542EUR$3,939USD£3,055GBP
- Report
- August 2025
- 192 Pages
Global
From €3188EUR$3,545USD£2,749GBP
€3542EUR$3,939USD£3,055GBP
- Report
- August 2025
- 189 Pages
Global
From €3188EUR$3,545USD£2,749GBP
€3542EUR$3,939USD£3,055GBP
- Report
- August 2025
- 198 Pages
Global
From €3188EUR$3,545USD£2,749GBP
€3542EUR$3,939USD£3,055GBP
![Loading Indicator](/images/loading.gif")
The HIV/AIDS Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs to treat HIV/AIDS. These drugs are used to treat the virus itself, as well as the symptoms and complications associated with it. HIV/AIDS drugs are typically divided into two categories: antiretroviral drugs, which are used to suppress the virus, and prophylactic drugs, which are used to prevent the transmission of the virus.
The HIV/AIDS Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the major players in the market include Gilead Sciences, Merck, GlaxoSmithKline, Bristol-Myers Squibb, and Pfizer. These companies are constantly developing new drugs and treatments to improve the quality of life for those living with HIV/AIDS. Show Less Read more
![Logo 91¿´Æ¬](/images/logo.svg"){kind=logo}
![Logo 91¿´Æ¬](/images/logo-research-and-markets-print.png"){kind=logo}